HK1071565A1 - 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines - Google Patents

6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines

Info

Publication number
HK1071565A1
HK1071565A1 HK05104374A HK05104374A HK1071565A1 HK 1071565 A1 HK1071565 A1 HK 1071565A1 HK 05104374 A HK05104374 A HK 05104374A HK 05104374 A HK05104374 A HK 05104374A HK 1071565 A1 HK1071565 A1 HK 1071565A1
Authority
HK
Hong Kong
Prior art keywords
substituted
inflammatory cytokines
pyrazolo
pyrazol
dihydro
Prior art date
Application number
HK05104374A
Other languages
English (en)
Inventor
Michael Phillip Clark
Matthew John Laufersweiler
Jane Far-Jine Djung
Michael George Natchus
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HK1071565A1 publication Critical patent/HK1071565A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK05104374A 2001-09-20 2005-05-24 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines HK1071565A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20
PCT/US2002/030135 WO2003024971A1 (en) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Publications (1)

Publication Number Publication Date
HK1071565A1 true HK1071565A1 (en) 2005-07-22

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05104163A HK1071366A1 (en) 2001-09-20 2005-05-18 Compounds which inhibit the release of inflammatory cytokines
HK05104374A HK1071565A1 (en) 2001-09-20 2005-05-24 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK05104163A HK1071366A1 (en) 2001-09-20 2005-05-18 Compounds which inhibit the release of inflammatory cytokines

Country Status (33)

Country Link
US (2) US6566357B1 (xx)
EP (3) EP1427728B1 (xx)
JP (3) JP2005504083A (xx)
KR (4) KR20060036125A (xx)
CN (3) CN1250551C (xx)
AR (3) AR037145A1 (xx)
AT (3) ATE332901T1 (xx)
AU (2) AU2002327690B2 (xx)
BR (3) BR0212905A (xx)
CA (3) CA2461072A1 (xx)
CO (3) CO5560590A2 (xx)
CY (1) CY1106398T1 (xx)
CZ (3) CZ2004345A3 (xx)
DE (3) DE60218704T2 (xx)
DK (2) DK1427732T3 (xx)
EG (2) EG24413A (xx)
ES (3) ES2237691T3 (xx)
HK (2) HK1071366A1 (xx)
HU (3) HUP0500752A2 (xx)
IL (3) IL160682A0 (xx)
MA (3) MA27066A1 (xx)
MX (3) MXPA04002569A (xx)
MY (2) MY129329A (xx)
NO (2) NO20041594L (xx)
NZ (3) NZ531063A (xx)
PE (3) PE20030474A1 (xx)
PL (3) PL370362A1 (xx)
PT (3) PT1427727E (xx)
RU (3) RU2299885C2 (xx)
SA (1) SA03230529B1 (xx)
SK (3) SK1502004A3 (xx)
WO (3) WO2003024973A1 (xx)
ZA (3) ZA200401260B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
EP1542680B1 (en) * 2002-09-09 2007-03-07 Amgen Inc. 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives as tnf-alpha and interleukin lowering agents for the treatment of inflammations
EP1608645B1 (de) * 2003-04-03 2007-05-02 MERCK PATENT GmbH Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
RU2450006C2 (ru) * 2006-04-18 2012-05-10 Эбботт Лэборетриз Антагонисты ванилоидного рецептора подтипа 1(vr1) и их применение
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
PE20120325A1 (es) * 2009-05-19 2012-04-12 Dow Agrosciences Llc Aminopirimidinas sustituidas con arilo como agentes fungicidas
WO2016205284A1 (en) 2015-06-15 2016-12-22 Cummins Inc. Combustion chamber elasticity device
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
WO2023076133A1 (en) * 2021-10-27 2023-05-04 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (xx) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
RU2269537C2 (ru) * 1999-09-07 2006-02-10 Зингента Партисипейшнс Аг Фенилзамещенные гетероциклические 1,3-кетоенолы, способ их получения, гербицидное средство на их основе и способ борьбы с ростом нежелательной растительности
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
KR20040035837A (ko) 2004-04-29
CN1555375A (zh) 2004-12-15
DE60213108D1 (de) 2006-08-24
NO20041605L (no) 2004-06-21
PE20030474A1 (es) 2003-07-22
KR20040035836A (ko) 2004-04-29
PL370415A1 (en) 2005-05-30
WO2003024971A1 (en) 2003-03-27
HUP0402378A2 (hu) 2005-02-28
DE60202782T2 (de) 2006-01-19
MA27065A1 (fr) 2004-12-20
KR100623879B1 (ko) 2006-09-19
RU2272040C2 (ru) 2006-03-20
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
ES2282459T3 (es) 2007-10-16
EP1427727A1 (en) 2004-06-16
EP1427732A1 (en) 2004-06-16
DK1427732T3 (da) 2006-10-30
HK1071366A1 (en) 2005-07-15
MA27064A1 (fr) 2004-12-20
PL370351A1 (en) 2005-05-16
AR037237A1 (es) 2004-11-03
IL160682A0 (en) 2004-08-31
JP2005504081A (ja) 2005-02-10
HUP0402500A3 (en) 2008-10-28
HUP0402378A3 (en) 2008-10-28
RU2299885C2 (ru) 2007-05-27
CZ2004345A3 (cs) 2004-06-16
EG24413A (en) 2009-05-25
NZ531063A (en) 2007-08-31
PT1427728E (pt) 2007-05-31
ATE356126T1 (de) 2007-03-15
BR0212716A (pt) 2004-08-03
DE60213108T2 (de) 2007-02-08
CO5560589A2 (es) 2005-09-30
KR20040035835A (ko) 2004-04-29
CA2461073A1 (en) 2003-03-27
AR037145A1 (es) 2004-10-27
NZ531123A (en) 2006-08-31
MA27066A1 (fr) 2004-12-20
PE20030430A1 (es) 2003-06-24
SK1502004A3 (en) 2004-09-08
BR0212673A (pt) 2004-08-24
CA2461071A1 (en) 2003-03-27
EP1427728A1 (en) 2004-06-16
ZA200401260B (en) 2004-08-30
CN1555379A (zh) 2004-12-15
SK1482004A3 (en) 2004-08-03
ZA200401403B (en) 2004-08-30
CZ2004361A3 (cs) 2004-07-14
CZ2004358A3 (cs) 2004-07-14
CN1250551C (zh) 2006-04-12
IL160742A0 (en) 2004-08-31
DK1427728T3 (da) 2007-07-09
EP1427732B1 (en) 2006-07-12
RU2004111806A (ru) 2005-03-27
CN1249066C (zh) 2006-04-05
MXPA04002574A (es) 2004-06-18
EP1427727B1 (en) 2005-01-26
MY129069A (en) 2007-03-30
CA2461072A1 (en) 2003-03-27
HUP0500752A2 (en) 2006-01-30
SA03230529B1 (ar) 2008-06-21
JP2005504083A (ja) 2005-02-10
US6566357B1 (en) 2003-05-20
EG24363A (en) 2009-03-04
ES2268154T3 (es) 2007-03-16
PL370362A1 (en) 2005-05-16
CO5560579A2 (es) 2005-09-30
SK1492004A3 (en) 2004-11-03
CY1106398T1 (el) 2011-10-12
MY129329A (en) 2007-03-30
CN1556811A (zh) 2004-12-22
AU2002327690B2 (en) 2006-07-20
BR0212905A (pt) 2004-10-13
NO20041594L (no) 2004-06-21
US6821971B2 (en) 2004-11-23
EP1427728B1 (en) 2007-03-07
MXPA04002569A (es) 2004-05-31
ATE287887T1 (de) 2005-02-15
KR100656126B1 (ko) 2006-12-12
CN1257905C (zh) 2006-05-31
RU2004111805A (ru) 2005-04-10
WO2003024973A1 (en) 2003-03-27
DE60218704T2 (de) 2007-11-08
PT1427732E (pt) 2006-12-29
KR20060036125A (ko) 2006-04-27
RU2278864C2 (ru) 2006-06-27
ES2237691T3 (es) 2005-08-01
DE60202782D1 (de) 2005-03-03
JP2005504082A (ja) 2005-02-10
ZA200401402B (en) 2004-08-27
PT1427727E (pt) 2005-06-30
WO2003024970A1 (en) 2003-03-27
US20030105084A1 (en) 2003-06-05
HUP0402500A2 (hu) 2005-03-29
AU2002334641B2 (en) 2007-03-29
IL160741A0 (en) 2004-08-31
NZ531122A (en) 2005-09-30
RU2004111803A (ru) 2005-10-10
DE60218704D1 (de) 2007-04-19
ATE332901T1 (de) 2006-08-15
PE20030446A1 (es) 2003-07-21
MXPA04002570A (es) 2004-05-31

Similar Documents

Publication Publication Date Title
HK1071565A1 (en) 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines
WO2003045929A1 (fr) Derive bicyclique, procede de production de ce derive et utilisation correspondante
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
WO2002089800A3 (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
MXPA03010129A (es) N-aroilaminas-ciclicas.
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
CA2532818A1 (en) (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
EP1566384A4 (en) AZOLINE DERIVATIVES
TW200505852A (en) Novel compounds
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
HRP20030566B1 (en) Improved process for carbapenem synthesis
HUP0500136A2 (hu) Oxitocin antagonista hatású szubsztituált diketo-piperazinok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP1364950A4 (en) PYRIDOPYRIMIDINE OR NAPHTHYRIDINE DERIVATIVE
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
WO2003004497A1 (fr) Compose heterocyclique
MY134226A (en) 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
IS7911A (is) Ímídasólafleiður með sækni í alfa 2 viðtakavirkni
NO20023298D0 (no) Nye imidazolderivater
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
GB0428137D0 (en) Novel herbicides
SE0400440D0 (sv) Novel Cinnamic Amides
NO20041601L (no) Forbindelse som hemmer frigjøringen av inflammatoriske cytokiner
EP1541571A4 (en) BICYCLIC, UNSATURATED TERTIARY AMINE COMPOUND
ES2026452T3 (es) Un procedimiento para preparar 6h-isoxazolo/ 3,4-d/pirazolo/3,4-b/piridinas.

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 20 TO JOURNAL OF 20050722: [54] 6,7-DIHYDRO-5H-PYRAZOLO[1,2-A]PYRAZOL-1-ONES WHICH CONTROL - INFLAMMATORY CYTOKINES; [72] CLARK, MICHAEL, PHILLIP W P - LAUFERSWEILER, MATTHEW, JOHN M J - DJUNG, JANE, FAR-JINE J F -J - NATCHUS, MICHAEL, GEORGE M G - DE, BISWANATH B

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100920